Clinical Trial Search block Test
A Phase 3, Open-label, and Rollover Study to Evaluate the Long-term Safety and Tolerability of Lumacaftor/Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation (VX19-445-124)
VX809_124_OLE
What is the goal of the study?
To learn more about this study, please email the study team member listed below.
Who can participate in the study?
Everyone